Following the initial trials in Africa of the groundbreaking drug that could put an end to AIDS | Science
Precious closes her eyes and clenches her fists as the syringe needle penetrates her right thigh, slowly injecting…
Gilead’s BIC LEN HIV Results Highlight Valuation Gap And Future Potential
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Gilead…
Greed Is a Hell of a Drug
On Sept. 24, the California-based multinational corporation Gilead Sciences announced it would lower the price of lenacapavir — a…